| Protein . | Sequence . | Tested HLA . | Actual HLA restriction . | ELISpot response rate (%) . | Intracellular staining . | Tetramer staining . | |
|---|---|---|---|---|---|---|---|
| 12-d stimulation . | Ex vivo (%)a . | ||||||
| pp65/UL83495–503 | NLVPMVATVb | A*02:01 | A*02:01 | 75.0 | 100.0 | CD8 | Positive |
| US874–82 | GVLDAVWRV | A*02:01 | A*02:01 | 72.2 | 50.0 | CD8 | Positive |
| UL150A152–161 | ALWDVALLEV | A*02:01 | A*02:01 | 71.4 | 25.0 | CD8 | Positive |
| gM/UL100200–208 | TLIVNLVEV | A*02:01 | A*02:01 | 55.0 | 25.0 | CD8 | Positive |
| UL44259–267 | GLFAVENFL | A*02:01 | HLA-II | 53.9 | 0.0 | CD4 | Not tested |
| UL16162–170 | YPRPPGSGLb | B*07:02 | B*07:02 | 86.4 | 25.0 | Negative | Positive |
| pp65/UL83417–426 | TPRVTGGGAMb | B*07:02 | B*07:02 | 81.6 | 100.0 | CD8 | Positive |
| TRS1166–174 | SPRDAWIVL | B*07:02 | B*07:02 | 68.2 | 20.0 | CD8 | Positive |
| UL52349–357 | SPSRDRFVQL | B*07:02 | B*07:02 | 66.7 | 33.3 | Negative | Positive |
| UL2322–30 | RPWKPGQRV | B*07:02 | B*07:02 | 53.6 | 66.7 | CD8 | Positive |
| UL4676–84 | SPRHLYISL | B*07:02 | B*07:02 | 50.0 | 0.0 | CD4/CD8 | Positive |
| UL112/UL113125–134 | SENGNLQVTY | B*44:02 | B*44:02 | 83.9 | 62.5 | CD8 | Positive |
| UL117358–366 | HETGVYQMW | B*44:02 | B*44:02 | 65.4 | 62.5 | CD8 | Positive |
| UL105715–723 | YADPFFLKYb | A*01:01 | A*01:01 | 100.0 | 90.9 | CD8 | Positive |
| UL44245–253 | VTEHDTLLYb | A*01:01 | A*01:01 | 92.9 | 100.0 | CD8 | Positive |
| UL69569–578 | RTDPATLTAY | A*01:01 | A*01:01 | 82.6 | 66.7 | CD8 | Positive |
| US28122–130 | ITEIALDRY | A*01:01 | A*01:01 | 58.3 | 14.3 | CD8 | Positive |
| gB/UL55657–665 | NTDFRVLELY | A*01:01 | A*01:01 | 56.3 | 0.0 | CD8 | Positive |
| UL77228–236 | GLYTQPRWK | A*03:01 | A*03:01 | 76.2 | 50.0 | CD8 | Positive |
| UL57790–798 | RVKNRPIYR | A*03:01 | A*03:01 | 60.9 | 33.3 | CD8 | Positive |
| UL34180–188 | LPHERHREL | B*08:01 | B*08:01 | 90.9 | 85.7 | CD8 | Positive |
| UL2661–69 | LPYPRGYTL | B*08:01 | B*08:01/51:01/14:02 | 68.8 | 16.7 | CD8 | Positive |
| UL13465–473 | YLVRRPMTI | B*08:01 | B*08:01 | 50.0 | 33.3 | Negative | Positive |
| pp65/UL83116–123 | LPLKMLNIb | B*51:01 | B*51:01 | 80.0 | 87.5 | CD8 | Positive |
| UL38156–164 | FPVEVRSHV | B*51:01 | B*51:01 | 65.2 | 0.0 | CD8 | Positive |
| UL2661–69 | LPYPRGYTL | B*51:01 | B*08:01/51:01/14:02 | 62.5 | 33.3 | CD8 | Positive |
| UL56503–511 | DARSRIHNV | B*51:01 | B*51:01 | 53.3 | 20.0 | CD8 | Positive |
| Protein . | Sequence . | Tested HLA . | Actual HLA restriction . | ELISpot response rate (%) . | Intracellular staining . | Tetramer staining . | |
|---|---|---|---|---|---|---|---|
| 12-d stimulation . | Ex vivo (%)a . | ||||||
| pp65/UL83495–503 | NLVPMVATVb | A*02:01 | A*02:01 | 75.0 | 100.0 | CD8 | Positive |
| US874–82 | GVLDAVWRV | A*02:01 | A*02:01 | 72.2 | 50.0 | CD8 | Positive |
| UL150A152–161 | ALWDVALLEV | A*02:01 | A*02:01 | 71.4 | 25.0 | CD8 | Positive |
| gM/UL100200–208 | TLIVNLVEV | A*02:01 | A*02:01 | 55.0 | 25.0 | CD8 | Positive |
| UL44259–267 | GLFAVENFL | A*02:01 | HLA-II | 53.9 | 0.0 | CD4 | Not tested |
| UL16162–170 | YPRPPGSGLb | B*07:02 | B*07:02 | 86.4 | 25.0 | Negative | Positive |
| pp65/UL83417–426 | TPRVTGGGAMb | B*07:02 | B*07:02 | 81.6 | 100.0 | CD8 | Positive |
| TRS1166–174 | SPRDAWIVL | B*07:02 | B*07:02 | 68.2 | 20.0 | CD8 | Positive |
| UL52349–357 | SPSRDRFVQL | B*07:02 | B*07:02 | 66.7 | 33.3 | Negative | Positive |
| UL2322–30 | RPWKPGQRV | B*07:02 | B*07:02 | 53.6 | 66.7 | CD8 | Positive |
| UL4676–84 | SPRHLYISL | B*07:02 | B*07:02 | 50.0 | 0.0 | CD4/CD8 | Positive |
| UL112/UL113125–134 | SENGNLQVTY | B*44:02 | B*44:02 | 83.9 | 62.5 | CD8 | Positive |
| UL117358–366 | HETGVYQMW | B*44:02 | B*44:02 | 65.4 | 62.5 | CD8 | Positive |
| UL105715–723 | YADPFFLKYb | A*01:01 | A*01:01 | 100.0 | 90.9 | CD8 | Positive |
| UL44245–253 | VTEHDTLLYb | A*01:01 | A*01:01 | 92.9 | 100.0 | CD8 | Positive |
| UL69569–578 | RTDPATLTAY | A*01:01 | A*01:01 | 82.6 | 66.7 | CD8 | Positive |
| US28122–130 | ITEIALDRY | A*01:01 | A*01:01 | 58.3 | 14.3 | CD8 | Positive |
| gB/UL55657–665 | NTDFRVLELY | A*01:01 | A*01:01 | 56.3 | 0.0 | CD8 | Positive |
| UL77228–236 | GLYTQPRWK | A*03:01 | A*03:01 | 76.2 | 50.0 | CD8 | Positive |
| UL57790–798 | RVKNRPIYR | A*03:01 | A*03:01 | 60.9 | 33.3 | CD8 | Positive |
| UL34180–188 | LPHERHREL | B*08:01 | B*08:01 | 90.9 | 85.7 | CD8 | Positive |
| UL2661–69 | LPYPRGYTL | B*08:01 | B*08:01/51:01/14:02 | 68.8 | 16.7 | CD8 | Positive |
| UL13465–473 | YLVRRPMTI | B*08:01 | B*08:01 | 50.0 | 33.3 | Negative | Positive |
| pp65/UL83116–123 | LPLKMLNIb | B*51:01 | B*51:01 | 80.0 | 87.5 | CD8 | Positive |
| UL38156–164 | FPVEVRSHV | B*51:01 | B*51:01 | 65.2 | 0.0 | CD8 | Positive |
| UL2661–69 | LPYPRGYTL | B*51:01 | B*08:01/51:01/14:02 | 62.5 | 33.3 | CD8 | Positive |
| UL56503–511 | DARSRIHNV | B*51:01 | B*51:01 | 53.3 | 20.0 | CD8 | Positive |